secwatch.observer — SEC 8-K summary
======================================

Issuer:     Raphael Pharmaceutical Inc. (RAPH)
CIK:        0001415397
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001213900-24-077706
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Raphael Pharmaceutical dismisses auditor Weinstein International, appoints Elkana Amitai CPA on short-term basis
--------------------------------------------------------------------------------

- Weinstein International CPA dismissed as independent auditor effective September 5, 2024.
- Prior auditor's reports for FY 2022 and 2023 contained a going concern qualification.
- New auditor Elkana Amitai CPA engaged for quarter ending September 30, 2024, on a short-term basis.
- No disagreements or reportable events occurred during the past two fiscal years and interim period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415397/000121390024077706/0001213900-24-077706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415397/000121390024077706/ea0214273-8k_raphael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer